The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: BG Group drags FTSE 100 lower, Syria concerns weigh

Mon, 09th Sep 2013 17:44

The FTSE 100 dropped into the red on Monday, pulling back after hitting a three-week high the previous session, as heavy falls from natural gas giant BG Group and ongoing concerns about Syria pressured stocks lower.London's benchmark index finished 16.59 points lower at 6,530.74, falling 0.25% from Friday's close of 6,547.33 which was its highest closing price since August 14th.Syria continues to be in focus this week ahead of a vote by US Congress over whether or not to proceed with a military attack after last month's alleged use of chemical weapons by Bashar Al-Assad's regime. Tensions at the G20 Summit escalated last week after Vladimir Putin said Russia would "assist" Syria if it was attacked by the US, just as President Barack Obama was trying to rally for support from global leaders for an intervention.Talks between US Secretary of State John Kerry and UK Foreign Secretary William Hague also caught the headlines this morning after Hague said the objectives and efforts of the US and UK "remain closely aligned". Kerry said that the relationship between the two countries was not affected by the UK's decision not engage in a military attack, but said that "the risk of not acting is greater than the risk of acting"."Despite the UK watching the Syria affair from the side-lines after the Prime Minister failed to secure parliamentary support for action, fallout from this vote will still be felt in the UK markets with oil prices and a potential flight to quality affecting both equity and Gilts," said Financial Sales Trader Alex Conroy.Uncertainty regarding Federal Reserve monetary policy also prompted traders to adopt a cautious approach in the aftermath of Friday's disappointing jobs report. A worse-than-expected rise in non-farm payrolls in August sparked speculation that the US central bank could hold off from tapering its quantitative easing (QE) programme until later on in the year. However, the unemployment rate fell last month from 7.4% to 7.3%.Chinese exports rise, Japan GDP revised upAsian markets performed well overnight after Chinese trade and inflation numbers brightened the third-quarter outlook for the world's second-largest economy. Chinese exports rose by a stronger-than-expected 7.2% in August and imports jumped by 7%, while the annual rate of consumer price inflation eased from 2.7% to 2.6%. Writing in Monday's Financial Times Chinese Premier Li Keqiang said that his country will stay the course on sustainable growth, by continuing to promote reforms, with an aim of meeting its 7.5% lower bound for gross domestic product (GDP) growth this year. Meanwhile, second-quarter GDP estimates in Japan were revised higher from 0.6% to 0.9%, as confidence grows in Prime Minister Shinzo Abe's so-called 'Abenomics'. While this was slightly lower than predictions, this data - along with the news that Tokyo will host the 2020 Olympics - gave the Nikkei 225 index a strong boost.FTSE 100: BG drops after cutting production guidanceOil and gas group BG was a heavy faller after lowering its 2014 production milestones due to the instability in Egypt, delays to the start-up of production in Norway and low natural gas prices in the US.Sugar and food group Tate & Lyle wasn't far behind after UBS downgraded the stock from 'neutral' to 'sell', saying that its current valuation is too high and does not reflect that "sucralose prices continue to decline as 'generic' competitors improve product quality and access greater scale".Food ingredients peer and retail group Associated British Foods was also lower despite saying a strong finish to the year from Primark will help it deliver adjusted operating profit ahead of expectations for the second half. Instead, the market was focusing on comments about low EU sugar prices next year.Mining stocks were putting in a mixed performance despite the strong data from top metals user China. Analysts at Citigroup said today that mining stocks could benefit from "additional short-term price momentum in the sector on positive rhetoric" following the category's underperformance so far this year compared with the UK market. "However, valuations are now looking more fully priced and we think the rally will fade into year end." The bank named Rio Tinto and Glencore Xstrata as its favoured stocks in the UK diversified mining sector, both of which were making gains today.GlaxoSmithKline declined after confirming it has reached an agreement to sell its Lucozade and Ribena brands to Japanese firm Suntory Beverage & Food for £1.35bn in cash. The company said that now is the right time to sell "as we increase the focus of our Consumer Healthcare business and execute the delivery of our late stage pipeline of pharmaceuticals and vaccines".FTSE 250: Icap and CSR lead gainsICAP is in talks about a settlement over its role in the Libor rate-rigging scandal which could see it pay about £70m ($109m) to British and US regulators, Sky News reported.Broker Liberum lited its target on CSR to buy, with a 550p price target. FTSE 100 - RisersARM Holdings (ARM) 917.50p +2.80%TUI Travel (TT.) 347.40p +2.72%Aviva (AV.) 399.80p +2.25%Burberry Group (BRBY) 1,635.00p +2.19%Lloyds Banking Group (LLOY) 76.78p +1.82%Kingfisher (KGF) 413.20p +1.67%ITV (ITV) 177.40p +1.66%Legal & General Group (LGEN) 193.80p +1.63%Whitbread (WTB) 3,216.00p +1.55%British Land Co (BLND) 557.50p +1.46%FTSE 100 - FallersBG Group (BG.) 1,217.00p -5.07%Tate & Lyle (TATE) 779.50p -3.41%Associated British Foods (ABF) 1,818.00p -1.78%Randgold Resources Ltd. (RRS) 4,914.00p -1.50%Petrofac Ltd. (PFC) 1,397.00p -1.34%Royal Dutch Shell 'A' (RDSA) 2,052.00p -1.27%Standard Chartered (STAN) 1,455.50p -1.12%United Utilities Group (UU.) 673.00p -1.10%Tullow Oil (TLW) 1,059.00p -1.03%HSBC Holdings (HSBA) 701.10p -1.02%FTSE 250 - RisersICAP (IAP) 417.80p +4.58%CSR (CSR) 517.50p +4.55%Barratt Developments (BDEV) 328.20p +4.36%888 Holdings (888) 146.90p +4.18%Enterprise Inns (ETI) 150.40p +3.72%Perform Group (PER) 523.50p +3.66%Bank of Georgia Holdings (BGEO) 1,810.00p +3.13%Debenhams (DEB) 104.50p +2.96%Halfords Group (HFD) 393.70p +2.79%Computacenter (CCC) 538.00p +2.77%FTSE 250 - FallersXaar (XAR) 760.00p -4.34%Petra Diamonds Ltd.(DI) (PDL) 122.90p -3.46%Salamander Energy (SMDR) 125.00p -3.40%Berendsen (BRSN) 906.50p -2.89%Bumi (BUMI) 211.20p -2.85%Kenmare Resources (KMR) 28.36p -2.54%Workspace Group (WKP) 430.60p -2.36%BTG (BTG) 368.00p -2.34%Brown (N.) Group (BWNG) 557.00p -2.28%Imagination Technologies Group (IMG) 287.10p -2.18%BC
More News
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.